Newsletter

397030 - April Bio Co., Ltd.

397030 Summary
Biopharma
Stock Price & Overview
₩18,180 +380 (+2.13%) Close · Sep 7, 2026 KST
KOSDAQ | ₩KRW | Close: ₩18,180  ≈ US$13  ·  Market cap ₩0.5tn (≈ $358m)
Home › 397030 › Filings

Resolution to convene an extraordinary general meeting

DART
April Bio Co., Ltd.
Filed Sep 7, 2026 KST · Filing · receipt 20260907900132

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 주주총회소집결의 (임시주주총회)

397030

Price
₩18,180
Change
+2.13%
Market cap
₩0.5tn
Prev. close
₩17,800
397030 SummaryCompare to Peers

397030 data on kstock

Financials
11 fiscal years

Every figure is taken from April Bio Co., Ltd.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 397030 filings

Notice of general meeting of shareholders

09/07/26

Insider / Major Shareholder Holdings Report

08/28/26

5% Ownership Report — Large Holdings

08/26/26

Material matter affecting investment judgment

08/21/26

Change of largest shareholder

08/19/26

Insider / Major Shareholder Holdings Report ×3

08/19/26
All 397030 filings